Shanghai Haohai Biological Technology Co., Ltd.SSE: 688366

Report for Q3 2025

Oct 25, 2025 · Issued by Shanghai Haohai Biological Technology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 25, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-622

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai Haohai Biological Technology Co., Ltd. on 6ix

Earlier from Shanghai Haohai Biological Technology

Announcement on Implementation of Semi-annual Dividend Distribution for 2025Oct 10, 2025
Announcement on Receipt of the Prior Notice of Administrative Penalty by One of the Company’s Controlling Shareholders and Actual Controllers Due to Non-company-related MattersSep 17, 2025
Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025Sep 6, 2025
Announcement on Semi-annual Profit Distribution Plan for 2025Aug 23, 2025
Announcement on Voluntary Disclosure of Execution of Termination AgreementAug 21, 2025

Later from Shanghai Haohai Biological Technology

Announcement on Using Temporarily Idle Raised Funds for Cash ManagementNov 8, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 28, 2025
Announcement on Opening Special Settlement Account for Cash Management Products of Raised FundsDec 11, 2025
Announcement on Canceling SomeRestricted Stock Granted but Not Yet Vested in 2021 A-share Restricted Stock Incentive PlanDec 13, 2025
Indicative Announcement on Cancellation of Repurchased H-shares and the Passive Equity Change of Controlling Shareholder, Actual Controller and Its Persons Acting in Concert Reaching 1% ScaleDec 30, 2025

All Shanghai Haohai Biological Technology news releases

Follow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.

Follow Shanghai Haohai Biological Technology